Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later.

Department of Psychiatry, University of California, San Francisco and San Francisco VA Medical Center, CA 94121, USA.
Schizophrenia Bulletin (Impact Factor: 8.61). 04/2009; 36(4):869-79. DOI: 10.1093/schbul/sbn170
Source: PubMed

ABSTRACT New cognitive treatments for schizophrenia are needed that drive persistent gains in cognition and functioning. Using an innovative neuroplasticity-based cognitive training approach, we report our interim findings on the effects on cognition and functional outcome at 6 months after treatment.
Thirty-two clinically stable schizophrenia subjects were randomly assigned to either targeted cognitive training (TCT, N = 22) or a computer games (CGs) control condition (N = 10). Twelve TCT subjects completed 50 hours of auditory based training; 10 TCT subjects completed an additional 50 hours of training targeting visual and cognitive control processes. Subjects were assessed on neurocognition and functional outcome after training and at 6-month follow-up.
Both TCT subject groups showed significant durable gains at 6 months on measures of verbal learning/memory and cognitive control. Only TCT subjects who completed 100 hours of training showed durable gains on processing speed and global cognition, with nonsignificant improvement in functional outcome. Improved cognition was significantly associated with improved functional outcome at 6 months for TCT subjects.
A total of 50 hours of neuroplasticity-based computerized cognitive training appears sufficient to drive improvements in verbal learning/memory and cognitive control that endure 6 months beyond the intervention, but a higher "dose" and more "broad-spectrum" training may be necessary to drive enduring gains in processing speed and global cognition. Training-induced cognitive improvement is related to enhanced functioning at 6 months. These data suggest that (1) higher and "broader" doses of cognitive training may confer the most benefits for schizophrenia patients; (2) the posttraining period opens a critical window for aggressive adjunctive psychosocial rehabilitation.

Download full-text


Available from: Karuna Subramaniam, Jun 27, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Emerging evidence of the validity of collecting data in natural settings using smartphone applications has opened new possibilities for psychological assessment, treatment, and research. In this study we explored the feasibility and effectiveness of using a mobile application for self-supervised training of auditory attention. In addition, we investigated the neural underpinnings of the training procedure with functional magnetic resonance imaging (fMRI), as well as possible transfer effects to untrained cognitive interference tasks. Subjects in the training group performed the training task on an iPod touch two times a day (morning/evening) for three weeks; subjects in the control group received no training, but were tested at the same time interval as the training group. Behavioral responses were measured before and after the training period in both groups, together with measures of task-related neural activations by fMRI. The results showed an expected performance increase after training that corresponded to activation decreases in brain regions associated with selective auditory processing (left posterior temporal gyrus) and executive functions (right inferior frontal gyrus), indicating more efficient processing in task-related neural networks after training. Our study suggests that cognitive training delivered via mobile applications is feasible and improves the ability to focus attention with corresponding effects on neural plasticity. Future research should focus on the clinical benefits of mobile-based cognitive training. Limitations of the study are discussed including reduced experimental control and lack of transfer effects.
    07/2014; 1(3). DOI:10.1016/j.invent.2014.06.001
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cognitive deficits in schizophrenia underlie more functional disability than any other symptom of the illness and existing treatments are largely inadequate. Non-invasive brain stimulation has been shown to enhance aspects of cognition in both healthy controls and patient populations; however there has been very little research into the use of tDCS for enhancing cognitive performance in schizophrenia. We conducted an initial investigation into the post stimulation effects of tDCS on cognitive performance in a repeated measures design in 18 patients with schizophrenia; in particular looking at dose of stimulation. Specifically, we provided a single 20-minute session of anodal left dorsolateral prefrontal tDCS (1 mA, 2 mA, sham) and measured performance on a working memory task across three time points post-stimulation (0, 20 and 40 min). Our results revealed a significant improvement in performance over time following 2 mA stimulation only. These findings speak to the feasibility of tDCS for enhancing cognitive performance in schizophrenia, as well as the importance of dose of stimulation.
    Schizophrenia Research 05/2014; 155(1-3). DOI:10.1016/j.schres.2014.03.006 · 4.43 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent research in neurodevelopment, neuroplasticity and genetics is providing new insights into the etiogenesis of psychopathology, but progress in treatment development has been hampered by reliance on diagnostic categories that are characterized by heterogeneity and based primarily on phenomenology. The NIMH Research Domain Criteria (RDoC) initiative seeks to provide a neuroscience-based nosological framework for future research on psychopathology, categorizing individuals for research purposes using a dimensional approach that capitalizes on advances in modern neuroscience. These scientific advances and new approaches to classification can inform the development of novel, circuit-based interventions and the personalization of treatment. In this paper, we review key advances areas in clinical neuroscience, describe the RDoC project and highlight some emerging treatment approaches that are consistent with these developments.
    07/2013; 32(1). DOI:10.3233/RNN-139015